Our response to the [comments][1] on our recent publication in Clinical and Vaccine Immunology ([1][2]) is as follows. The authors state that the conclusions “are misleading and inconsistent with previous publications on the efficacy of canarypox-FeLV vaccine ([2][3][–][4][5][5]).” The first